{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:00:25Z","timestamp":1793120425525,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"51","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.vaccine.2008.09.041","type":"journal-article","created":{"date-parts":[[2008,10,8]],"date-time":"2008-10-08T16:56:01Z","timestamp":1223484961000},"page":"6655-6663","source":"Crossref","is-referenced-by-count":26,"title":["Naturally-occurring human serum antibodies to inner core lipopolysaccharide epitopes of Neisseria meningitidis protect against invasive meningococcal disease caused by isolates displaying homologous inner core structures"],"prefix":"10.1016","volume":"26","author":[{"given":"Anne","family":"J\u00e4kel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce S.","family":"Plested","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Claire","family":"Hoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Makepeace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret-Anne J.","family":"Gidney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Lacelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"St. Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Richard","family":"Moxon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.09.041_bib1","series-title":"Meningococcal disease","first-page":"115","article-title":"Meningococcal carriage and disease","author":"Cartwright","year":"1995"},{"key":"10.1016\/j.vaccine.2008.09.041_bib2","series-title":"New generation vaccines","first-page":"421","article-title":"Meningococcal conjugate and protein-based vaccines","author":"Rappuoli","year":"2004"},{"issue":"8346","key":"10.1016\/j.vaccine.2008.09.041_bib3","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","article-title":"Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis","volume":"2","author":"Finne","year":"1983","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2008.09.041_bib4","first-page":"125","article-title":"Results of an efficacy trial with an outer membrane vesicle vaccine against systemic serogroup B meningococcal disease in Norway","volume":"14","author":"Bjune","year":"1991","journal-title":"NIPH Ann"},{"issue":"9","key":"10.1016\/j.vaccine.2008.09.041_bib5","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0264-410X(94)00037-N","article-title":"Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Chilean National Committee for Meningococcal Disease","volume":"13","author":"Boslego","year":"1995","journal-title":"Vaccine"},{"issue":"8827","key":"10.1016\/j.vaccine.2008.09.041_bib6","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/0140-6736(92)93086-3","article-title":"Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil","volume":"340","author":"de Moraes","year":"1992","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2008.09.041_bib7","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1086\/514232","article-title":"Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland","volume":"177","author":"Perkins","year":"1998","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2008.09.041_bib8","first-page":"195","article-title":"Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba","volume":"14","author":"Sierra","year":"1991","journal-title":"NIPH Ann"},{"issue":"Part 11","key":"10.1016\/j.vaccine.2008.09.041_bib9","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1099\/00221287-144-11-3027","article-title":"Immunization with recombinant class 1 outer-membrane protein from Neisseria meningitidis: influence of liposomes and adjuvants on antibody avidity, recognition of native protein and the induction of a bactericidal immune response against meningococci","volume":"144","author":"Christodoulides","year":"1998","journal-title":"Microbiology"},{"issue":"6","key":"10.1016\/j.vaccine.2008.09.041_bib10","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1128\/IAI.69.6.3809-3816.2001","article-title":"Immunization with recombinant Opc outer membrane protein from Neisseria meningitidis: influence of sequence variation and levels of expression on the bactericidal immune response against meningococci","volume":"69","author":"Jolley","year":"2001","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2008.09.041_bib11","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1128\/IAI.70.8.4028-4034.2002","article-title":"Immunization with the recombinant PorB outer membrane protein induces a bactericidal immune response against Neisseria meningitidis","volume":"70","author":"Wright","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.09.041_bib12","series-title":"Handbook of meningococcal disease","first-page":"163","article-title":"Genetics, structure and function of lipopolysaccharide","author":"Wright","year":"2006"},{"issue":"4","key":"10.1016\/j.vaccine.2008.09.041_bib13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/10408419891294216","article-title":"Genetic basis for biosynthesis, structure, and function of meningococcal lipooligosaccharide (endotoxin)","volume":"24","author":"Kahler","year":"1998","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.vaccine.2008.09.041_bib14","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1139\/v90-160","article-title":"Structure of L1 and L6 core oligosaccharide epitopes of Neisseria meningitidis","volume":"68","author":"Di Fabio","year":"1990","journal-title":"Can J Chem"},{"issue":"2","key":"10.1016\/j.vaccine.2008.09.041_bib15","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0021-9258(18)48372-X","article-title":"Structure of the L2 lipopolysaccharide core oligosaccharides of Neisseria meningitidis","volume":"267","author":"Gamian","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2008.09.041_bib16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0008-6215(83)84020-8","article-title":"The structure of an R-type oligosaccharide core obtained from some lipopolysaccharides of Neisseria meningitidis","volume":"121","author":"Jennings","year":"1983","journal-title":"Carbohydr Res"},{"issue":"3","key":"10.1016\/j.vaccine.2008.09.041_bib17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0008-6215(96)00305-9","article-title":"Structural basis of the Neisseria meningitidis immunotypes including the L4 and L7 immunotypes","volume":"298","author":"Kogan","year":"1997","journal-title":"Carbohydr Res"},{"issue":"13","key":"10.1016\/j.vaccine.2008.09.041_bib18","doi-asserted-by":"crossref","first-page":"7243","DOI":"10.1016\/S0021-9258(19)39105-7","article-title":"Structure of the L5 lipopolysaccharide core oligosaccharides of Neisseria meningitidis","volume":"265","author":"Michon","year":"1990","journal-title":"J Biol Chem"},{"issue":"19","key":"10.1016\/j.vaccine.2008.09.041_bib19","doi-asserted-by":"crossref","first-page":"14146","DOI":"10.1016\/S0021-9258(19)85220-1","article-title":"Structure of the sialylated L3 lipopolysaccharide of Neisseria meningitidis","volume":"268","author":"Pavliak","year":"1993","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.vaccine.2008.09.041_bib20","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1099\/00222615-41-4-236","article-title":"Lipo-oligosaccharide immunotyping of Neisseria meningitidis by a whole-cell ELISA with monoclonal antibodies","volume":"41","author":"Scholten","year":"1994","journal-title":"J Med Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.09.041_bib21","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1046\/j.1432-1327.1998.2540626.x","article-title":"Structure of an alpha-2,6-sialylated lipooligosaccharide from Neisseria meningitidis immunotype L1","volume":"254","author":"Wakarchuk","year":"1998","journal-title":"Eur J Biochem"},{"issue":"16","key":"10.1016\/j.vaccine.2008.09.041_bib22","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0008-6215(02)00161-1","article-title":"Structural analysis of the lipopolysaccharide from Neisseria meningitidis strain BZ157 galE: localisation of two phosphoethanolamine residues in the inner core oligosaccharide","volume":"337","author":"Cox","year":"2002","journal-title":"Carbohydr Res"},{"issue":"4","key":"10.1016\/j.vaccine.2008.09.041_bib23","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1046\/j.1365-2958.2002.02754.x","article-title":"Identification of a gene (lpt-3) required for the addition of phosphoethanolamine to the lipopolysaccharide inner core of Neisseria meningitidis and its role in mediating susceptibility to bactericidal killing and opsonophagocytosis","volume":"43","author":"Mackinnon","year":"2002","journal-title":"Mol Microbiol"},{"issue":"20","key":"10.1016\/j.vaccine.2008.09.041_bib24","doi-asserted-by":"crossref","first-page":"6970","DOI":"10.1128\/JB.186.20.6970-6982.2004","article-title":"lpt6, a gene required for addition of phosphoethanolamine to inner-core lipopolysaccharide of Neisseria meningitidis and Haemophilus influenzae","volume":"186","author":"Wright","year":"2004","journal-title":"J Bacteriol"},{"issue":"Part 11","key":"10.1016\/j.vaccine.2008.09.041_bib25","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1099\/00221287-145-11-3013","article-title":"The genetic basis of the phase variation repertoire of lipopolysaccharide immunotypes in Neisseria meningitidis","volume":"145","author":"Jennings","year":"1999","journal-title":"Microbiology"},{"issue":"43","key":"10.1016\/j.vaccine.2008.09.041_bib26","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1016\/j.vaccine.2005.06.011","article-title":"Candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: developmental chemistry and investigation of immunological responses following immunization of mice and rabbits","volume":"23","author":"Cox","year":"2005","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2008.09.041_bib27","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.1128\/IAI.67.10.5417-5426.1999","article-title":"Conservation and accessibility of an inner core lipopolysaccharide epitope of Neisseria meningitidis","volume":"67","author":"Plested","year":"1999","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2008.09.041_bib28","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral antibodies","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.vaccine.2008.09.041_bib29","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1128\/CVI.00102-07","article-title":"Seroprevalence of bactericidal and anti-outer membrane vesicle antibodies to Neisseria meningitidis group B in England","volume":"14","author":"Trotter","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.09.041_bib30","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1128\/IAI.62.4.1437-1443.1994","article-title":"Humoral immune response to class 1 outer membrane protein during the course of meningococcal disease","volume":"62","author":"Guttormsen","year":"1994","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2008.09.041_bib31","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1128\/IAI.57.5.1590-1598.1989","article-title":"Human immune response to meningococcal outer membrane protein epitopes after natural infection or vaccination","volume":"57","author":"Mandrell","year":"1989","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2008.09.041_bib32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/infdis\/150.1.71","article-title":"Immune response of infants and children to disseminated infections with Neisseria meningitidis","volume":"150","author":"Griffiss","year":"1984","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2008.09.041_bib33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1365-2958.1993.tb01962.x","article-title":"Cloning and molecular analysis of the galE gene of Neisseria meningitidis and its role in lipopolysaccharide biosynthesis","volume":"10","author":"Jennings","year":"1993","journal-title":"Mol Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.09.041_bib34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0378-1097(96)00484-3","article-title":"Analysis of the icsBA locus required for biosynthesis of the inner core region from Neisseria meningitidis lipopolysaccharide","volume":"146","author":"van der Ley","year":"1997","journal-title":"FEMS Microbiol Lett"},{"issue":"4","key":"10.1016\/j.vaccine.2008.09.041_bib35","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1365-2958.1995.mmi_18040729.x","article-title":"Molecular analysis of a locus for the biosynthesis and phase-variable expression of the lacto-N-neotetraose terminal lipopolysaccharide structure in Neisseria meningitidis","volume":"18","author":"Jennings","year":"1995","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2008.09.041_bib36","first-page":"83","article-title":"Bacterial lipopolysaccharide extraction with water\u2013phenol and further applications of the procedure","volume":"43","author":"Westphal","year":"1965","journal-title":"Methods Carbohydr Chem"},{"issue":"2","key":"10.1016\/j.vaccine.2008.09.041_bib37","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0003-2697(78)90260-9","article-title":"A new and improved microassay to determine 2-keto-3-deoxyoctonate in lipopolysaccharide of Gram-negative bacteria","volume":"85","author":"Karkhanis","year":"1978","journal-title":"Anal Biochem"},{"issue":"31\u201332","key":"10.1016\/j.vaccine.2008.09.041_bib38","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1016\/j.vaccine.2004.04.027","article-title":"Immunogenicity and safety of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine as a pre-school booster in UK children","volume":"22","author":"Collins","year":"2004","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vaccine.2008.09.041_bib39","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1001\/jama.283.21.2795","article-title":"Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: a randomized controlled trial","volume":"283","author":"MacLennan","year":"2000","journal-title":"J Am Med Assoc"},{"issue":"1","key":"10.1016\/j.vaccine.2008.09.041_bib40","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1128\/IAI.72.1.559-569.2004","article-title":"Development, characterization, and functional activity of a panel of specific monoclonal antibodies to inner core lipopolysaccharide epitopes in Neisseria meningitidis","volume":"72","author":"Gidney","year":"2004","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2008.09.041_bib41","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.carres.2007.10.015","article-title":"Preparation of glycoconjugates by dialkyl squarate chemistry revisited","volume":"343","author":"Hou","year":"2008","journal-title":"Carbohydr Res"},{"issue":"3","key":"10.1016\/j.vaccine.2008.09.041_bib42","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1021\/ac60111a017","article-title":"Colorimetric method for determination of sugars and related substances","volume":"28","author":"DuBois","year":"1956","journal-title":"Anal Chem"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2008.09.041_bib43","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-1759(00)00142-3","article-title":"Enzyme linked immunosorbent assay (ELISA) for the detection of serum antibodies to the inner core lipopolysaccharide of Neisseria meningitidis group B","volume":"237","author":"Plested","year":"2000","journal-title":"J Immunol Methods"},{"issue":"8","key":"10.1016\/j.vaccine.2008.09.041_bib44","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1086\/368360","article-title":"Highly conserved Neisseria meningitidis inner-core lipopolysaccharide epitope confers protection against experimental meningococcal bacteremia","volume":"187","author":"Plested","year":"2003","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2008.09.041_bib45","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1128\/IAI.69.5.3203-3213.2001","article-title":"Functional opsonic activity of human serum antibodies to inner core lipopolysaccharide (galE) of serogroup B meningococci measured by flow cytometry","volume":"69","author":"Plested","year":"2001","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2008.09.041_bib46","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.4049\/jimmunol.131.3.1443","article-title":"Studies on the mechanism of bacterial resistance to complement-mediated killing. IV. C5b-9 forms high molecular weight complexes with bacterial outer membrane constituents on serum-resistant but not on serum-sensitive Neisseria gonorrhoeae","volume":"131","author":"Joiner","year":"1983","journal-title":"J Immunol"},{"issue":"51","key":"10.1016\/j.vaccine.2008.09.041_bib47","doi-asserted-by":"crossref","first-page":"50853","DOI":"10.1074\/jbc.M308364200","article-title":"Neisserial lipooligosaccharide is a target for complement component C4b. Inner core phosphoethanolamine residues define C4b linkage specificity","volume":"278","author":"Ram","year":"2003","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.vaccine.2008.09.041_bib48","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1128\/IAI.00882-06","article-title":"Affinity-purified human immunoglobulin G that binds a lacto-N-neotetraose-dependent lipooligosaccharide structure is bactericidal for serogroup B Neisseria meningitidis","volume":"75","author":"Estabrook","year":"2007","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2008.09.041_bib49","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1128\/MMBR.57.1.34-49.1993","article-title":"Meningococcal lipopolysaccharides: virulence factor and potential vaccine component","volume":"57","author":"Verheul","year":"1993","journal-title":"Microbiol Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2008.09.041_bib50","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/infdis\/137.2.112","article-title":"Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children","volume":"137","author":"Gold","year":"1978","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2008.09.041_bib51","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1128\/IAI.73.4.2424-2432.2005","article-title":"Genetic diversity and carriage dynamics of Neisseria lactamica in infants","volume":"73","author":"Bennett","year":"2005","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2008.09.041_bib52","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1017\/S0950268800066449","article-title":"The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica","volume":"99","author":"Cartwright","year":"1987","journal-title":"Epidemiol Infect"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2008.09.041_bib53","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1016\/j.vaccine.2005.01.055","article-title":"The development of a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles","volume":"23","author":"Gorringe","year":"2005","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2008.09.041_bib54","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1128\/JB.183.3.942-950.2001","article-title":"Structural and immunochemical characterization of the lipooligosaccharides expressed by Neisseria subflava 44","volume":"183","author":"Tong","year":"2001","journal-title":"J Bacteriol"},{"issue":"18","key":"10.1016\/j.vaccine.2008.09.041_bib55","doi-asserted-by":"crossref","first-page":"10872","DOI":"10.1073\/pnas.95.18.10872","article-title":"Identification of the gene (lgtG) encoding the lipooligosaccharide beta chain synthesizing glucosyl transferase from Neisseria gonorrhoeae","volume":"95","author":"Banerjee","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.vaccine.2008.09.041_bib56","article-title":"Characterization of the key antigenic components and pre-clinical immune responses to a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles","volume":"3","author":"Finney","year":"2007","journal-title":"Hum Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2008.09.041_bib57","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1128\/CVI.00341-07","article-title":"Immunity to Neisseria meningitidis group B in adults despite lack of serum bactericidal antibody","volume":"14","author":"Welsch","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.09.041_bib58","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1128\/CVI.00036-08","article-title":"Vaccine-induced opsonophagocytic immunity to Neisseria meningitidis group B","volume":"15","author":"Plested","year":"2008","journal-title":"Clin Vaccine Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08012498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08012498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T13:23:26Z","timestamp":1709299406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08012498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":58,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0264410X08012498"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.09.041","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}